Apex Biotechnology Corp Free Cash Flow Generation Index
Apex Biotechnology Corp free cash flow generation index. Apex Biotechnology Corp (1733) has a Free Cash Flow Generation Index of 0.43x as of September 2025. Free cash flow of NT$2.22 Million represents 0% of operating cash flow (NT$5.19 Million).
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Free Cash Flow Generation Index of Apex Biotechnology Corp (2002–2024)
Free cash flow generation index of Apex Biotechnology Corp from 2002 to 2024. Historical FCF Generation Index trend for Apex Biotechnology Corp across 23 annual periods. See 1733 free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
Apex Biotechnology Corp Free Cash Flow Generation Index by Year (2002–2024)
Apex Biotechnology Corp free cash flow generation index by year from 2002 to 2024. Year-by-year Free Cash Flow Generation Index for Apex Biotechnology Corp. For the full cash flow conversion analysis, see 1733 cash flow metrics.
| Year | FCG Index | Free Cash Flow (TWD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.91x | NT$299.04 Million | NT$328.67 Million | NT$29.63 Million | ▲ +2.0% |
| 2023 | 0.89x | NT$205.41 Million | NT$230.39 Million | NT$24.98 Million | ▲ +274.7% |
| 2022 | -0.51x | NT$-13.58 Million | NT$26.62 Million | NT$40.20 Million | ▼ -159.7% |
| 2021 | 0.85x | NT$153.67 Million | NT$179.87 Million | NT$26.20 Million | ▲ +3.2% |
| 2020 | 0.83x | NT$232.28 Million | NT$280.60 Million | NT$48.32 Million | ▼ -5.7% |
| 2019 | 0.88x | NT$405.94 Million | NT$462.52 Million | NT$56.58 Million | ▲ +867.9% |
| 2018 | -0.11x | NT$-7.72 Million | NT$67.57 Million | NT$75.29 Million | ▼ -118.4% |
| 2017 | 0.62x | NT$44.07 Million | NT$70.83 Million | NT$26.76 Million | ▼ -28.6% |
| 2016 | 0.87x | NT$259.60 Million | NT$298.06 Million | NT$38.45 Million | ▼ -7.7% |
| 2015 | 0.94x | NT$445.49 Million | NT$472.15 Million | NT$26.66 Million | ▲ +24.9% |
| 2014 | 0.76x | NT$202.19 Million | NT$267.60 Million | NT$65.41 Million | ▲ +54.5% |
| 2013 | 0.49x | NT$237.08 Million | NT$484.77 Million | NT$247.69 Million | ▲ +162.5% |
| 2012 | 0.19x | NT$94.96 Million | NT$509.67 Million | NT$414.70 Million | ▼ -74.4% |
| 2011 | 0.73x | NT$198.82 Million | NT$273.45 Million | NT$74.63 Million | ▲ +11.2% |
| 2010 | 0.65x | NT$304.53 Million | NT$465.59 Million | NT$161.05 Million | ▼ -19.5% |
| 2009 | 0.81x | NT$317.95 Million | NT$391.29 Million | NT$73.34 Million | ▼ -43.3% |
| 2008 | 1.43x | NT$429.70 Million | NT$299.96 Million | NT$129.74 Million | ▲ +24.6% |
| 2007 | 1.15x | NT$419.34 Million | NT$364.62 Million | NT$54.71 Million | ▲ +3.1% |
| 2006 | 1.12x | NT$405.70 Million | NT$363.71 Million | NT$41.99 Million | ▼ -19.4% |
| 2005 | 1.38x | NT$293.44 Million | NT$212.14 Million | NT$81.30 Million | ▼ -35.6% |
| 2004 | 2.15x | NT$469.70 Million | NT$218.54 Million | NT$251.16 Million | ▲ +81.2% |
| 2003 | 1.19x | NT$358.46 Million | NT$302.25 Million | NT$56.21 Million | ▼ -33.0% |
| 2002 | 1.77x | NT$140.62 Million | NT$79.49 Million | NT$61.13 Million | — |